Back
Cellectis SA 10K Form
Sell
43
CLLS
Cellectis SA
Last Price:
2.50
Seasonality Move:
2.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLLS News And Ratings
See the #1 stock for the next 7 days that we like better than CLLS
CLLS Financial Statistics
Sales & Book Value
| Annual Sales: | $19.17M |
|---|---|
| Cash Flow: | $-17.41M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.37 |
| Price / Book: | 2.36 |
Profitability
| EPS (TTM): | -1.67000 |
|---|---|
| Net Income (TTM): | $-85.02M |
| Gross Margin: | $17.4M |
| Return on Equity: | -78.57% |
| Return on Assets: | -34.57% |
Cellectis SA Earnings Forecast
Key Cellectis SA Financial Ratios
- The Gross Profit Margin over the past 16 years for CLLS is 90.76%.
- The Selling, General & Administrative Expenses for CLLS have been equal to 56.24% of Gross Profit Margin.
- The Research & Development expenses have been 508.59% of Revenue.
- The Interest Expense is -3.57% of Operating Income.
- The Net Earning history of CLLS is -553.64% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 5 years.
Cellectis SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLLS |
| CUSIP: | 15117K |
| Website: | cellectis.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 2.2 |
| Quick Ratio: | 2.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLLS Technical Analysis vs Fundamental Analysis
Sell
43
Cellectis SA (CLLS)
is a Sell
Is Cellectis SA a Buy or a Sell?
-
Cellectis SA stock is rated a Sell
The current Cellectis SA [CLLS] share price is $2.51. The Score for CLLS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.